Context The use of stereotactic ablative radiotherapy for recurrent and metastatic renal cell
carcinoma (RCC) is not yet standard treatment due to uncertainties regarding its efficacy and …

The use of stereotactic body radiotherapy for metastatic spinal tumours is increasing.
Serious adverse events for this treatment include vertebral compression fracture (VCF) and …

Background To report the primary endpoint of a randomized trial comparing pain response
following palliative stereotactic body radiation therapy (SBRT) versus conventionally …

Conventional radiotherapy previously had a limited role in the definitive treatment of renal
cell carcinoma (RCC), owing to the disappointing outcomes of several trials and the …

Background Stereotactic radiotherapy (SBRT) might improve pain and local control in
patients with bone metastases compared to conventional radiotherapy, although an overall …

Renal cell carcinoma (RCC) is the most common neoplasm of adult kidney. One of the
important unmet medical needs in RCC is prognostic biomarker enabling identification of …

Metastatic breast cancer has traditionally been considered incurable, with treatments
focused on systemic therapies and palliative local treatment. However, evidence is …

Renal cell carcinoma (RCC) accounts for 3% of adult malignancies and is the eighth leading
cause of cancer in the United States. 1 Worldwide, 400,000 people were diagnosed and …

Purpose Stereotactic body radiation therapy (SBRT) is being applied more widely for
oligometastatic disease. This technique is now being used for non-spine bony metastases in …

Abstract Stereotactic Body Radiotherapy (SBRT) is a technique for delivering high doses of
radiation to tumors while preserving the normal tissues located around this area. Bone …